Analyst Price Targets — SYK
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 31, 2026 1:53 pm | Shagun Singh | RBC Capital | $420.00 | $321.09 | TheFly | Stryker price target lowered to $420 from $435 at RBC Capital |
| July 31, 2026 12:54 pm | — | Raymond James | $370.00 | $322.69 | TheFly | Stryker price target lowered to $370 from $383 at Raymond James |
| July 31, 2026 12:12 pm | Ryan Zimmerman | BTIG | $358.00 | $322.13 | TheFly | Stryker price target lowered to $358 from $371 at BTIG |
| July 31, 2026 11:36 am | — | Piper Sandler | $390.00 | $348.37 | TheFly | Stryker price target lowered to $390 from $420 at Piper Sandler |
| July 31, 2026 9:36 am | — | Wolfe Research | $375.00 | $348.37 | StreetInsider | Stryker (SYK) PT Raised to $375 at Wolfe ResearchMember Login |
| July 13, 2026 11:20 am | — | BTIG | $371.00 | $329.78 | TheFly | Stryker price target lowered to $371 from $379 at BTIG |
| July 9, 2026 1:22 pm | — | Argus Research | $370.00 | $328.79 | TheFly | Stryker price target raised to $370 from $350 at Argus |
| July 8, 2026 8:26 pm | — | BMO Capital | $369.00 | $326.85 | TheFly | Stryker initiated with an Outperform at BMO Capital |
| July 6, 2026 12:48 pm | — | Evercore ISI | $350.00 | $319.22 | TheFly | Stryker price target lowered to $350 from $355 at Evercore ISI |
| June 5, 2026 9:16 am | Mike Kratky | Leerink Partners | $407.00 | $301.21 | StreetInsider | Stryker (SYK) PT Lowered to $407 at Leerink |
Latest News for SYK
SYK's FDA-cleared SportSuite Vision brings Apple Vision Pro into hip arthroscopy, strengthening its digital surgery push and Sports Medicine portfolio.
SYK's planned ZuriMED acquisition adds the FiberLocker System, aiming to strengthen its shoulder portfolio and rotator cuff care capabilities.
SportSuite Vision brings spatial computing into the operating room, providing surgeons access to critical clinical information Stryker announced the successful completion of the first surgical procedure, a hip arthroscopy, using SportSuite Vision on Apple Vision Pro at a leading academic medical center. Stryker received FDA De Novo authorization for the first surgical application for intraoperative use with Apple…
Portage, Mich., USA, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, announced it has signed a definitive agreement to acquire ZuriMED, a privately held company and developer of the FiberLocker® System. This commercialized technology provides a novel approach for rotator cuff augmentation with increased biomechanical strength to address a key clinical failure mode in…
Caisse de depot et placement du Quebec bought a new position in shares of Stryker Corporation (NYSE: SYK) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 6,529 shares of the medical technology company's stock, valued at approximately $2,056,000. Other hedge funds
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.